The ONCASPAR IV brand, founded in 2008 (United States), from 3 sister brands and 2214 competing brands. ONCASPAR IV is owned by Enzon Pharmaceuticals, listed on the stock exchange of Etats-Unis ONCASPAR IV is part of the Biotechnology activity sector.
Buy Enzon Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
